Next Generation RadioHybrids for Theranostic Applications
The Science
We are fostering innovations in all aspects of radioligand development including chelators, linkers, and conjugation chemistry combined with novel biologics and peptides for diagnosis and treatment of cancer and neurological disorders
The Products
Our pipelines consist of diagnostic and theranostic platforms.
The Applications
Theranostic platform for oncology
PET radiotracers for detection of biomarkers in cancer and treatment guidance combined with alpha-therapy for effective treatment of cancer
Radiotracers for neurological disorders
18F-radiolabeled small molecules and peptides for detection of metabolic and immune biomarkers associated with Alzheimer’s disease and stroke
Assessment of immunotherapy
PET radiotracers for detection of activity of cytotoxic effectors expressed upon successful immunotherapy